Assessment & Research

Research in mental retardation: underreporting of medication information.

Agran et al. (1988) · Research in developmental disabilities 1988
★ The Verdict

Hidden medication information still threatens behavior-analytic clarity 35 years later.

✓ Read this if BCBAs who write behavior plans for clients with intellectual disability.
✗ Skip if Clinicians who only treat med-free populations.

01Research in Context

01

What this study did

The authors read every article in six developmental-disability journals for 11 years. They counted how many papers said what drugs the participants took. Only 3 % of studies listed current meds. Only 1.5 % tested meds as part of the experiment.

02

What they found

Medication facts are missing from 97 % of research papers. This gap hides possible drug-behavior links. Behavior analysts cannot tell if a skill jump or problem drop came from teaching or from a new pill.

03

How this fits with other research

Christian et al. (1997) did the same count nine years later. Reporting rose, but still only 40 % of ID studies and 60 % of ADHD studies named meds. The trend is up, yet most drug details stay hidden.

Katz et al. (2003) stepped further. They showed that when medication studies do happen, they use weak designs. Small samples, no blinding, no behavior data. The 1988 warning about missing info became a 2003 call for better science.

Ballester et al. (2022) moved the gap from journals to clinics. They found only 64 adverse events recorded in 83 heavily medicated adults. Under-reporting is not just a paper problem; it hides harm in real time.

04

Why it matters

You need the full picture to plan good behavior programs. Ask families, nurses, and doctors for current med lists at intake. Note dose changes in your session log. If behavior shifts, you will know if a new pill or your teaching did the work. This simple habit protects your data and your clients.

Free CEUs

Want CEUs on This Topic?

The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.

Join Free →
→ Action — try this Monday

Add a medication line to your intake form and update it every two weeks.

02At a glance

Intervention
not applicable
Design
systematic review
Population
intellectual disability
Finding
not reported

03Original abstract

Estimates of psychoactive drug use among persons residing in community and institutional settings suggest high prevalence rates. Psychoactive drug use has been associated with impairments in adaptive functioning. As a result, drug-induced effects may represent potential confounds that need to be considered when evaluating treatment outcomes. Consequently, information about drug regimens should be reported in empirical investigations. In this investigation, a review of six applied research and special education journals over an 11-year period was conducted to determine the extent to which information about drug regimens of participants was provided. It was determined that only slightly more than 3% of the articles reported information about subject medication usage and only 1.5% reported information relating to the use of medications as independent variables. The results are discussed in terms of their implications for recommending that providing information about drug regimens should become standard practice when describing subjects.

Research in developmental disabilities, 1988 · doi:10.1016/0891-4222(88)90030-3